Parkinson’s World

health data

The Cure Parkinson’s Trust has been chosen by the City-based philanthropy group, The October Club, as the beneficiary charity for their annual fundraising dinner to be held in October to raise funds for a new online project, Parkinson’s World. This will link patient experience with clinical and scientific expertise and aim to be the definitive information resource for both people living with Parkinson’s and also the wider Parkinson’s community. The resource will collect information, which will enable better stratification of the condition, which in turn will create new avenues of research into ways to slow, stop and reverse the disease.

Click this link to read more about Parkinson’s World. Parkinsons_World_summary

 

RELATED ITEMS

  • World Parkinson Congress 2016 World Parkinson Congress (WPC), the only Parkinson’s conference to draw together people with Parkinson’s, researchers and clinical experts took place in Portland, Oregon, USA from 20th to 23rd September 2016. We have just got back from a very busy and interesting trip! Tom Isaac honoured with Distinguished…
  • A psychological journey with Parkinson’s For me, Parkinson’s has been a strange journey which has generated some major highs and some quite extraordinary lows. Oddly, most of the lows were in my early years with the condition, even though this was a time when my symptoms were at their least…
  • Because I have a background in neuroscience in addition to my earned experience as a person with Parkinson's, I'm often asked whether I believe there will be a cure for Parkinson's. Sometimes I'm asked openly in Q and A sessions at public meetings. Every so often though, someone will sidle…
  • Progress in Parkinson’s, both in terms of its management and improvements to its treatment, is extremely slow. There have been advances in the understanding of Parkinson’s and there is the very real possibility of therapies with the capacity to modify the course of the condition in the pipeline. However, these…
  • GRAND RAPIDS, Mich. (February 22, 2016)—A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus of a new clinical trial for Parkinson’s disease. The trial is the latest to be launched as part of the Linked Clinical Trials (LCT) initiative,…